Epirol 200mg Tablet

    Epirol 200mg Tablet

    S3
    PDF Leaflet Revision Date: 15 October 1984


    Clinical Summary

    Quick overview from the medicine insert

    Indication

    Used for petit mal, grand mal, and temporal lobe epilepsy.

    Dosage (summary)

    Adults: Start at 600 mg/day, increase by 200 mg every 3 days; max 2600 mg/day. Children: 20-50 mg/kg/day based on weight.

    Special Populations

    • Renal impairment
    • Hepatic impairment

    Pregnancy & Breastfeeding

    Avoid in pregnancy unless essential; teratogenic risk in first trimester.

    Key Drug Interactions

    • May enhance sedative effects of barbiturates
    • Potentiates MAO inhibitors

    Contraindications

    • Pregnancy
    • Hepatic dysfunction

    Common side effects

    • Nausea
    • Tremor
    • Hair loss
    • Gastric irritation

    Counselling Points

    • Take with food
    • Monitor for bleeding
    • Report abdominal pain
    • Avoid in pregnancy

    Serious warnings

    • Risk of hepatic failure
    • Monitor liver function
    • Potential for hyperammonaemia
    Important Disclaimer

    The Epirol 200mg Tablet professional information leaflet below is the property of Oethmaan Biosims and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>

    Healthcare Professionals Only

    This content is for registered healthcare professionals

    Sign in or create a free account to read the full package insert.

    Free for HPCSA-registered professionals. Powered by Medinsert.

    Successfully Stashed! 💊

    This package insert has been safely stored in your digital medical cabinet. No prescription needed to view it later!

    View My Favourites
    WhatsApp Email LinkedIn